DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Prorenone
Prorenone
Compositions Comprising Drospirenone Molecularly
The Organic Chemistry of Drug Synthesis
(19) United States (12) Patent Application Publication (10) Pub
Drug Insight: Eplerenone, a Mineralocorticoid- Receptor Antagonist Frances Mcmanus, Gordon T Mcinnes and John MC Connell*
The Organic Chemistry of Drug Synthesis
Autacoids Introduction
(12) Patent Application Publication (10) Pub. No.: US 2004/0058896 A1 Dietrich Et Al
EVIDENCE of GENE EXPRESSION and ENZYME ACTIVITY By
A Computational Study of the Substrate Conversion and Selective Inhibition of Aldosterone Synthase
European Patent Office of Opposition to That Patent, in Accordance with the Implementing Regulations
STARLING REVIEW the New Biology of Aldosterone
Molecular Evolution of the Switch for Progesterone and Spironolactone from Mineralocorticoid Receptor Agonist to Antagonist
(12) United States Patent (10) Patent No.: US 8,715,735 B2 Funke Et Al
U Ottawa L.'Univcrsilc Cnnndicnnc Cnnadn's University Inn FACULTE DES ETUDES SUPERIEURES FACULTY of GRADUATE and ET POSTOCTORALES U Ottawa POSDOCTORAL STUDIES
WO 2015/070019 Al 14 May 2015 (14.05.2015) P O P C T
WO 2016/141182 Al 9 September 2016 (09.09.2016) P O P C T
Molecular Evolution of the Switch for Progesterone and Spironolactone from Mineralocorticoid Receptor Agonist to Antagonist
Spironolactone - Wikipedia
Top View
Long-Term Extension Study to Assess Vamorolone in Boys
The Organic Chemistry of Drug Synthesis Vol 4
Correlation with Animal Experience G.T
The Organic Chemistry of Drug Synthesis
Mineralocorticoid Receptor Antagonists: Achieving Cardiovascular Benefit with Minimized Renal Side Effects? European Heart Journal 34 2426–2428
(12) Patent Application Publication (10) Pub. No.: US 2005/0207990 A1 Funke Et Al